First author Felix Trottmann at a mass spectrometer.
First author Felix Trottmann at a mass spectrometer.

Image source: Anna Schroll/Leibniz-HKI

News • Rare but dangerous infectious disease

New target to combat Melioidosis

Researchers at the Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (Leibniz-HKI) have identified an enzyme that is a promising new therapeutic target to combat the dangerous bacterial disease melioidosis.

It helps the pathogenic bacterium Burkholderia pseudomallei construct a toxic molecule that is critical in the infection process. The results were published in Nature Chemistry

Melioidosis is a life-threatening disease caused by the bacterium Burkholderia pseudomallei. "Without treatment, the disease is usually fatal," Christian Hertweck, head of the Biomolecular Chemistry Department at Leibniz-HKI and professor of Natural Product Chemistry at Friedrich Schiller University in Jena, explains. "And even antibiotic treatment often drags on for many months and is not always successful because common drugs do not work well against these pathogens."

Photo
Active centre of the enzyme BurG, which forms a highly reactive chemical compound that plays a crucial role in melioidosis.

Image source: Michael Groll/Felix Trottmann

His research group therefore wanted to understand the bacterium's infection mechanisms and has come across a possible new starting point for combating the disease. "We have found an enzyme that synthesises a molecular structure central to the infection," explains Felix Trottmann, first author of the study. 

The discovered enzyme BurG forms a cyclopropanol ring, a highly reactive chemical functional group, from a precursor molecule. In previous studies, Trottmann was able to demonstrate that this structure is also produced by other pathogenic bacteria in the genus Burkholderia and apparently has an important role in infection. If the biosynthetic pathway for this molecule is switched off by mutations, the bacteria are far less dangerous. 

The research team has also elucidated the 3D structure of the enzyme in cooperation with Michael Groll from TU Munich. "In a next step, we can now try to design active compounds that inhibit the enzyme and thus make the bacteria less virulent," Trottmann explains. According to current knowledge, the enzyme is only found in bacteria and not in humans. "The hope is therefore to be able to specifically inhibit the bacteria," says Hertweck. The immune system could then deal with them more easily.

To understand the biosynthesis of the molecular structure central to infection, the researchers investigated the gene cluster that contains the DNA instructions for making it. They conducted the laboratory experiments using Burkholderia thailandensis, which is very similar to Burkholderia pseudomallei but is much safer to work with. 

Melioidosis mainly occurs in Southeast Asia and Australia. However, experts warn that the disease could spread further. For example, the US Centers for Disease Control and Prevention (CDC) were able to trace the cause of four cases of melioidosis last year, two of which were fatal, to an aromatherapy spray. A closely related species, B. mallei, which also produces the cyclopropanol ring, was used as a biological weapon in both World War I and World War II. And B. pseudomallei was also researched as such in some countries. 


Source: Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute

01.08.2022

Read all latest stories

Related articles

Photo

News • Greenhouse gas emissions

How climate change impacts human pathogenic diseases

A comprehensive assessment of scientific literature has uncovered empirical evidence that more than 58% of human diseases caused by pathogens, such as dengue, hepatitis, pneumonia, malaria, Zika,…

Photo

News • CD4-PP vs. UTI

Reducing the risk of infection for patients with urinary catheters

Indwelling catheters through the urethra often cause bacterial infections. A newly discovered synthetic peptide is a promising treatment option, even against antibiotic-resistant pathogens.

Photo

News • Protective coating

Researchers develop spray-on 'Covid shield'

A sprayable coating that can prevent the surface spread of infection from bacteria and viruses – including Covid-19 – over a sustained period has been developed by Australian researchers.

Related products

Shimadzu – CLAM-2030

Mass Spectrometry

Shimadzu – CLAM-2030

Shimadzu Europa GmbH
Shimadzu – MALDImini-1

Research Use Only

Shimadzu – MALDImini-1

Shimadzu Europa GmbH
Alsachim - Dosimmune immunosupressant Alsachim – kit (CE-IVD or RUO)

Clinical Chemistry

Alsachim - Dosimmune immunosupressant Alsachim – kit (CE-IVD or RUO)

Alsachim, a Shimadzu Group Company
Alsachim – Dosimyco immunosupressant reagent kit (RUO)

Clinical Chemistry

Alsachim – Dosimyco immunosupressant reagent kit (RUO)

Alsachim, a Shimadzu Group Company
Associates of Cape Cod – Fungitell STAT Assay

Identification/Susceptibility

Associates of Cape Cod – Fungitell STAT Assay

Associates of Cape Cod Europe GmbH
Subscribe to Newsletter